title: Effect of combined deferasirox and 5-azacytidine treatment on human leukemia cells in vitro.
authors.affiliation: Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishishinjuku, Tokyo, 160-0023, Japan, s-ima@tokyo-med.ac.jp.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Imanishi
authors.forename: Ryoko
authors.initials: R
authors.lastname: Takahashi
authors.forename: Miho
authors.initials: M
authors.lastname: Ohsuga
authors.forename: Kazuma
authors.initials: K
authors.lastname: Ohyashiki
authors.forename: Junko H
authors.initials: JH
authors.lastname: Ohyashiki
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D001374:Azacitidine / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D000077588:Deferasirox; D018922:HL-60 Cells; D006801:Humans; D007502:Iron Chelating Agents / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D014230:Triazoles / Q000494:pharmacology; D020298:U937 Cells
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D001374:Azacitidine; D000077588:Deferasirox